Sign in
Taking peopleNo phase

Ketogenic diet added to care for high-grade glioma and brain metastases

Tests a ketogenic diet alongside usual care in adults with brain tumors.

Key facts

Who runs it
Attikon Hospital
Where
Greece2 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases
Status
Recruiting
People taking part
15 people, planned
Started
20 Sept 2022
Planned end
28 Feb 2026
Type of study
Interventional
Treatments tested
  • CKD
Record updated
31 May 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with high-grade brain tumours (glioblastoma) or cancer that has spread to the brain. They will follow a classic ketogenic diet (very low in sugar and starch, high in fat) for 3 months.

Age
18 to 80 years
Sex
All sexes
Disease stage
Newly diagnosed glioblastoma grade 4 confirmed by tissue test, or secondary brain metastases, or tumour growth after surgery, radiation and chemotherapy. Karnofsky Performance Score (a measure of daily functioning) of 50 or more.
Earlier treatment
People whose disease grew after surgical removal, radiation and chemotherapy can join, as can newly diagnosed people.

Main reasons for not taking part

  • Diabetes mellitus
  • Life expectancy >3 months (as written in the record)
  • Not able to follow the diet
  • Gallbladder removal in the last 1 year
  • A genetic disorder of fat metabolism

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age 18-80
  • Karnofsky Performance Score of 50 or more
  • Newly diagnosed, histologically confirmed glioblastoma grade 4, or secondary metastases or progression after surgical resection, radiation and chemotherapy
  • Normal function of liver and kidneys
  • Ability to sign informed consent form

Who cannot take part

  • Diabetes mellitus
  • Diagnosis of genetic disorder of fat metabolism
  • Life expectancy >3 months
  • Inability to adhere to diet
  • Inability to give informed consent form
  • Cholecystectomy last 1 year (before the study entry)

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

This trial is currently available in Greece.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The survival interval of patients with gliomas ranges between 12 to 15 months. Recent findings revealed that dietary interventions to reduce glucose and glycolytic pathways could have a therapeutic effect. Ketosis can be an effective therapy to extend the survival of patients with gliomas.

The group in the trial

  • Classic Ketogenic DietTreatment being tested

    Patients will adhere to a classic ketogenic diet for a period of 3 months with a possible extension depending on their compliance on the diet.

    Treatment: CKD

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A "Classic" Ketogenic Diet as a Complementary Therapeutic Management on Patients With High-grade Gliomas and Brain Metastases.
Plain-language title
Ketogenic diet added to care for high-grade glioma and brain metastasesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT05564949, who can take part
Record updated
31 May 2025